Galapagos | Lånekapital



Loan Capital Ändra Datum
AstraZeneca USD 27.73B 2.29B 2024-12
Biogen USD 4.55B 1.4M 2024-12
Genmab DKK 937M 41M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Incyte USD 33.54M 5.32M 2024-12
Merck EUR 7.88B 62M 2024-09
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
UCB EUR 2.82B 166M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Galapagos Lånekapital - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.